Clorox Co (NYSE:CLX) Shares Sold by Decatur Capital Management Inc.

Decatur Capital Management Inc. lessened its stake in shares of Clorox Co (NYSE:CLX) by 28.0% in the third quarter, Holdings Channel.com reports. The fund owned 23,602 shares of the company’s stock after selling 9,175 shares during the quarter. Decatur Capital Management Inc.’s holdings in Clorox were worth $3,584,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Heritage Wealth Advisors purchased a new stake in shares of Clorox in the second quarter valued at $30,000. Transamerica Financial Advisors Inc. purchased a new stake in shares of Clorox in the second quarter valued at $41,000. Mirova purchased a new stake in shares of Clorox in the second quarter valued at $47,000. Nelson Van Denburg & Campbell Wealth Management Group LLC lifted its holdings in shares of Clorox by 45.9% in the third quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 334 shares of the company’s stock valued at $50,000 after purchasing an additional 105 shares in the last quarter. Finally, Prestige Wealth Management Group LLC purchased a new stake in shares of Clorox in the second quarter valued at $53,000. Institutional investors own 78.18% of the company’s stock.

Shares of NYSE CLX traded up $0.36 during mid-day trading on Friday, reaching $151.11. The company had a trading volume of 293,327 shares, compared to its average volume of 1,172,253. Clorox Co has a twelve month low of $141.53 and a twelve month high of $167.70. The company has a debt-to-equity ratio of 4.09, a quick ratio of 0.55 and a current ratio of 0.91. The stock has a market capitalization of $18.79 billion, a PE ratio of 23.91, a price-to-earnings-growth ratio of 5.05 and a beta of 0.40. The stock’s 50 day moving average is $155.39 and its 200-day moving average is $155.38.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Thursday, August 1st. The company reported $1.88 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.84 by $0.04. Clorox had a net margin of 13.20% and a return on equity of 118.88%. The business had revenue of $1.63 billion for the quarter, compared to the consensus estimate of $1.69 billion. During the same period in the prior year, the business posted $1.66 earnings per share. Clorox’s revenue for the quarter was down 3.8% compared to the same quarter last year. On average, sell-side analysts anticipate that Clorox Co will post 6.14 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Wednesday, October 30th will be paid a $1.06 dividend. This represents a $4.24 dividend on an annualized basis and a dividend yield of 2.81%. The ex-dividend date of this dividend is Tuesday, October 29th. Clorox’s dividend payout ratio (DPR) is presently 67.09%.

A number of analysts have recently issued reports on CLX shares. ValuEngine lowered Clorox from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Citigroup reduced their target price on Clorox from $167.00 to $163.00 and set a “neutral” rating for the company in a report on Thursday, October 3rd. Royal Bank of Canada increased their target price on Clorox to $161.00 and gave the company a “sector perform” rating in a report on Friday, August 2nd. Morgan Stanley restated an “underweight” rating and issued a $134.00 target price (down previously from $144.00) on shares of Clorox in a report on Monday, September 30th. Finally, Zacks Investment Research raised shares of Clorox from a “sell” rating to a “hold” rating and set a $175.00 price target on the stock in a research note on Monday, July 29th. Four investment analysts have rated the stock with a sell rating, eight have given a hold rating and two have assigned a buy rating to the stock. Clorox presently has a consensus rating of “Hold” and an average price target of $152.25.

In other Clorox news, SVP Michael R. Costello sold 6,997 shares of the stock in a transaction on Wednesday, September 4th. The shares were sold at an average price of $162.56, for a total transaction of $1,137,432.32. Following the transaction, the senior vice president now directly owns 29,016 shares of the company’s stock, valued at $4,716,840.96. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director A D. David Mackay sold 3,400 shares of the stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $154.87, for a total transaction of $526,558.00. The disclosure for this sale can be found here. Insiders sold 15,609 shares of company stock worth $2,497,443 over the last ninety days. 1.14% of the stock is currently owned by company insiders.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

See Also: Commodities

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.